Skip to Main Content

Envision Healthcare Corporation Securities Fraud Class Action

View Complaint
COMPANY         Envision Healthcare Corporation
COURT United States District Court for the Middle District of Tennessee
CASE NUMBER 17-cv-01112
JUDGE The Hon. William Lynn Campbell Jr.
CLASS PERIOD February 3, 2014 - October 31, 2017

Case Background:

On August 4, 2017, the initial complaint in this securities class action was filed against Envision Healthcare Corporation (“Envision” or the “Company”) and certain of Envision’s directors and officers, asserting violations of Sections 10(b) and 20(a) of the Securities Exchange Act.  At all relevant times, EmCare Holdings, Inc. (“EmCare”) has been one of the Company’s primary operating subsidiaries. This is a federal securities class action brought on behalf of all persons who purchased or otherwise acquired the common stock of Envision between February 3, 2014 and October 31, 2017, both dates inclusive (the “Class Period”). 

The complaint alleges that throughout the class period, Defendants made materially false and misleading statements regarding the Company’s business, operations and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) EmCare routinely arranged for patients who sought treatment at in-network facilities to be treated by out-of-network physicians; (2) EmCare accordingly billed these patients at higher rates than if the patients had received treatment from in-network physicians; (3) the Company’s statements attributing EmCare’s Class Period growth to other factors were therefore false and/or misleading; (4) Envision’s EmCare revenues were likely to be unsustainable after the foregoing conduct came to light; and (5) as a result of the foregoing, Envision’s public statements were materially false and misleading at all relevant times.

Current Status of Case:

On December 13, 2021, Lead Plaintiffs filed an Amended Complaint. On September 29, 2022, the Court issued an Order denying Defendants Motion to Dismiss.  On September 22, 2023, Lead Plaintiffs filed a Motion for Preliminary Approval of Settlement. 

If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; or via e-mail at If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.

Please complete this form and list your purchase and sale transaction(s) for Envision Healthcare Corporation f/k/a Envision Healthcare Holdings, Inc. (NYSE: EVHC) securities between February 3, 2014  and October 31, 2017, both dates inclusive (the “Class Period”):

You may also contact Jon Naji, Esq. at (484) 270-1453; or you may submit your information via email at, or you may click here to print a PDF of this form.

* Denotes required field
# of Shares
Price per Share
Principal Amount
Amount Paid
Series or CUSIP
# of Contracts
Price per Contract
Exercise Price
Expiration Date
Did you purchase shares of Envision Healthcare Corporation (2017) prior to the Class Period?
Are you a current or former employee of Envision Healthcare Corporation (2017)?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.
I agree to the KTMC disclaimer
I would like to receive new case alerts by email